Downregulation of lactosylceramide synthases B4GALT5 or B4GALT6 alters glycosphingolipid profiles and enhances oxaliplatin sensitivity in colon cancer cells
Downregulation of lactosylceramide synthases B4GALT5 or B4GALT6 alters glycosphingolipid profiles and enhances oxaliplatin sensitivity in colon cancer cells. // Current Research in Toxicology. – URL: https://www.sciencedirect.com/science/article/pii/S2666027X26000277?dgcid=rss_sd_all
Downregulation of lactosylceramide synthases B4GALT5 or B4GALT6 alters glycosphingolipid profiles and enhances oxaliplatin sensitivity in colon cancer cells. Current Research in Toxicology. https://www.sciencedirect.com/science/article/pii/S2666027X26000277?dgcid=rss_sd_all
“Downregulation of lactosylceramide synthases B4GALT5 or B4GALT6 alters glycosphingolipid profiles and enhances oxaliplatin sensitivity in colon cancer cells.” Current Research in Toxicology.
@article{article3042,
title = {Downregulation of lactosylceramide synthases B4GALT5 or B4GALT6 alters glycosphingolipid profiles and enhances oxaliplatin sensitivity in colon cancer cells},
journal = {Current Research in Toxicology},
url = {https://www.sciencedirect.com/science/article/pii/S2666027X26000277?dgcid=rss_sd_all}
}